COVID-19 Impact on Global Chimeric Antigen Receptor Cell Therapy Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-chimeric-antigen-receptor-cell-therapy-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Chimeric Antigen Receptor Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chimeric Antigen Receptor Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Amgen Inc
- Autolus Therapeutics Plc
- Beijing Immunochina Medical Science & Technology Co Ltd
- Bellicum Pharmaceuticals Inc
- Bristol-Myers Squibb Co
- bluebird bio Inc
- CARsgen Therapeutics Ltd
- Celgene Corp
- Cell Medica Ltd
- Cellular Biomedicine Group Inc
- Celularity Inc
- Celyad SA
- Daiichi Sankyo Co Ltd
- Fosun Pharmaceutical AG
- Gilead Sciences Inc
- Guangzhou Anjie Biomedical Technology Co Ltd
- Hangzhou Converd Co Ltd
- Hebei Senlang Biotechnology Inc Ltd
- HRAIN Biotechnology Co Ltd
- Juno Therapeutics Inc
- Kite Pharma Inc
- Nanjing Legend Biotech Co Ltd
- NantKwest Inc
- Nkarta Inc
- Novartis AG
- Ono Pharmaceutical Co Ltd
- Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- Sorrento Therapeutics Inc
- Takara Bio Inc
- Monotherapy
- Combination Therapy
- Acute Leukemia
- Non-hodgkin's Lymphoma
- Multiple Myeloma
- Transplant Rejection
- Other
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Chimeric Antigen Receptor Cell Therapy status, future forecast, growth opportunity, key market and key players.
- To present the Chimeric Antigen Receptor Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Acute Leukemia
1.5.3 Non-hodgkin's Lymphoma
1.5.4 Multiple Myeloma
1.5.5 Transplant Rejection
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Chimeric Antigen Receptor Cell Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Chimeric Antigen Receptor Cell Therapy Industry
1.6.1.1 Chimeric Antigen Receptor Cell Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chimeric Antigen Receptor Cell Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chimeric Antigen Receptor Cell Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Chimeric Antigen Receptor Cell Therapy Market Perspective (2015-2026)
2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Regions
2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chimeric Antigen Receptor Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Chimeric Antigen Receptor Cell Therapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Market Size
3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio
3.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2019
3.3 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
3.4 Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
3.5 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2021-2026)
5 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
6.2 Chimeric Antigen Receptor Cell Therapy Key Players in North America (2019-2020)
6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
7.2 Chimeric Antigen Receptor Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
8.2 Chimeric Antigen Receptor Cell Therapy Key Players in China (2019-2020)
8.3 China Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
8.4 China Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
9.2 Chimeric Antigen Receptor Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
10.2 Chimeric Antigen Receptor Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
11.2 Chimeric Antigen Receptor Cell Therapy Key Players in India (2019-2020)
11.3 India Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
11.4 India Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
12.2 Chimeric Antigen Receptor Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Amgen Inc
13.1.1 Amgen Inc Company Details
13.1.2 Amgen Inc Business Overview and Its Total Revenue
13.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020))
13.1.5 Amgen Inc Recent Development
13.2 Autolus Therapeutics Plc
13.2.1 Autolus Therapeutics Plc Company Details
13.2.2 Autolus Therapeutics Plc Business Overview and Its Total Revenue
13.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction
13.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.2.5 Autolus Therapeutics Plc Recent Development
13.3 Beijing Immunochina Medical Science & Technology Co Ltd
13.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
13.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview and Its Total Revenue
13.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
13.4 Bellicum Pharmaceuticals Inc
13.4.1 Bellicum Pharmaceuticals Inc Company Details
13.4.2 Bellicum Pharmaceuticals Inc Business Overview and Its Total Revenue
13.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.4.5 Bellicum Pharmaceuticals Inc Recent Development
13.5 Bristol-Myers Squibb Co
13.5.1 Bristol-Myers Squibb Co Company Details
13.5.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction
13.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.5.5 Bristol-Myers Squibb Co Recent Development
13.6 bluebird bio Inc
13.6.1 bluebird bio Inc Company Details
13.6.2 bluebird bio Inc Business Overview and Its Total Revenue
13.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.6.5 bluebird bio Inc Recent Development
13.7 CARsgen Therapeutics Ltd
13.7.1 CARsgen Therapeutics Ltd Company Details
13.7.2 CARsgen Therapeutics Ltd Business Overview and Its Total Revenue
13.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.7.5 CARsgen Therapeutics Ltd Recent Development
13.8 Celgene Corp
13.8.1 Celgene Corp Company Details
13.8.2 Celgene Corp Business Overview and Its Total Revenue
13.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction
13.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.8.5 Celgene Corp Recent Development
13.9 Cell Medica Ltd
13.9.1 Cell Medica Ltd Company Details
13.9.2 Cell Medica Ltd Business Overview and Its Total Revenue
13.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.9.5 Cell Medica Ltd Recent Development
13.10 Cellular Biomedicine Group Inc
13.10.1 Cellular Biomedicine Group Inc Company Details
13.10.2 Cellular Biomedicine Group Inc Business Overview and Its Total Revenue
13.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.10.5 Cellular Biomedicine Group Inc Recent Development
13.11 Celularity Inc
10.11.1 Celularity Inc Company Details
10.11.2 Celularity Inc Business Overview and Its Total Revenue
10.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.11.5 Celularity Inc Recent Development
13.12 Celyad SA
10.12.1 Celyad SA Company Details
10.12.2 Celyad SA Business Overview and Its Total Revenue
10.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction
10.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.12.5 Celyad SA Recent Development
13.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Company Details
10.13.2 Daiichi Sankyo Co Ltd Business Overview and Its Total Revenue
10.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.13.5 Daiichi Sankyo Co Ltd Recent Development
13.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Company Details
10.14.2 Fosun Pharmaceutical AG Business Overview and Its Total Revenue
10.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction
10.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.14.5 Fosun Pharmaceutical AG Recent Development
13.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Company Details
10.15.2 Gilead Sciences Inc Business Overview and Its Total Revenue
10.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.15.5 Gilead Sciences Inc Recent Development
13.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview and Its Total Revenue
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
13.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Company Details
10.17.2 Hangzhou Converd Co Ltd Business Overview and Its Total Revenue
10.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.17.5 Hangzhou Converd Co Ltd Recent Development
13.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
10.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview and Its Total Revenue
10.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
13.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Company Details
10.19.2 HRAIN Biotechnology Co Ltd Business Overview and Its Total Revenue
10.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.19.5 HRAIN Biotechnology Co Ltd Recent Development
13.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Company Details
10.20.2 Juno Therapeutics Inc Business Overview and Its Total Revenue
10.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.20.5 Juno Therapeutics Inc Recent Development
13.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Company Details
10.21.2 Kite Pharma Inc Business Overview and Its Total Revenue
10.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.21.5 Kite Pharma Inc Recent Development
13.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Company Details
10.22.2 Nanjing Legend Biotech Co Ltd Business Overview and Its Total Revenue
10.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.22.5 Nanjing Legend Biotech Co Ltd Recent Development
13.23 NantKwest Inc
10.23.1 NantKwest Inc Company Details
10.23.2 NantKwest Inc Business Overview and Its Total Revenue
10.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.23.5 NantKwest Inc Recent Development
13.24 Nkarta Inc
10.24.1 Nkarta Inc Company Details
10.24.2 Nkarta Inc Business Overview and Its Total Revenue
10.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.24.5 Nkarta Inc Recent Development
13.25 Novartis AG
10.25.1 Novartis AG Company Details
10.25.2 Novartis AG Business Overview and Its Total Revenue
10.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction
10.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.25.5 Novartis AG Recent Development
13.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Company Details
10.26.2 Ono Pharmaceutical Co Ltd Business Overview and Its Total Revenue
10.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.26.5 Ono Pharmaceutical Co Ltd Recent Development
13.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview and Its Total Revenue
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
13.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Company Details
10.28.2 Sorrento Therapeutics Inc Business Overview and Its Total Revenue
10.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.28.5 Sorrento Therapeutics Inc Recent Development
13.29 Takara Bio Inc
10.29.1 Takara Bio Inc Company Details
10.29.2 Takara Bio Inc Business Overview and Its Total Revenue
10.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.29.5 Takara Bio Inc Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Acute Leukemia
1.5.3 Non-hodgkin's Lymphoma
1.5.4 Multiple Myeloma
1.5.5 Transplant Rejection
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Chimeric Antigen Receptor Cell Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Chimeric Antigen Receptor Cell Therapy Industry
1.6.1.1 Chimeric Antigen Receptor Cell Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chimeric Antigen Receptor Cell Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chimeric Antigen Receptor Cell Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Chimeric Antigen Receptor Cell Therapy Market Perspective (2015-2026)
2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Regions
2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chimeric Antigen Receptor Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Chimeric Antigen Receptor Cell Therapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Market Size
3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio
3.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2019
3.3 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
3.4 Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
3.5 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2021-2026)
5 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
6.2 Chimeric Antigen Receptor Cell Therapy Key Players in North America (2019-2020)
6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
7.2 Chimeric Antigen Receptor Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
8.2 Chimeric Antigen Receptor Cell Therapy Key Players in China (2019-2020)
8.3 China Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
8.4 China Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
9.2 Chimeric Antigen Receptor Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
10.2 Chimeric Antigen Receptor Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
11.2 Chimeric Antigen Receptor Cell Therapy Key Players in India (2019-2020)
11.3 India Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
11.4 India Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
12.2 Chimeric Antigen Receptor Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Amgen Inc
13.1.1 Amgen Inc Company Details
13.1.2 Amgen Inc Business Overview and Its Total Revenue
13.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020))
13.1.5 Amgen Inc Recent Development
13.2 Autolus Therapeutics Plc
13.2.1 Autolus Therapeutics Plc Company Details
13.2.2 Autolus Therapeutics Plc Business Overview and Its Total Revenue
13.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction
13.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.2.5 Autolus Therapeutics Plc Recent Development
13.3 Beijing Immunochina Medical Science & Technology Co Ltd
13.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
13.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview and Its Total Revenue
13.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
13.4 Bellicum Pharmaceuticals Inc
13.4.1 Bellicum Pharmaceuticals Inc Company Details
13.4.2 Bellicum Pharmaceuticals Inc Business Overview and Its Total Revenue
13.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.4.5 Bellicum Pharmaceuticals Inc Recent Development
13.5 Bristol-Myers Squibb Co
13.5.1 Bristol-Myers Squibb Co Company Details
13.5.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction
13.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.5.5 Bristol-Myers Squibb Co Recent Development
13.6 bluebird bio Inc
13.6.1 bluebird bio Inc Company Details
13.6.2 bluebird bio Inc Business Overview and Its Total Revenue
13.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.6.5 bluebird bio Inc Recent Development
13.7 CARsgen Therapeutics Ltd
13.7.1 CARsgen Therapeutics Ltd Company Details
13.7.2 CARsgen Therapeutics Ltd Business Overview and Its Total Revenue
13.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.7.5 CARsgen Therapeutics Ltd Recent Development
13.8 Celgene Corp
13.8.1 Celgene Corp Company Details
13.8.2 Celgene Corp Business Overview and Its Total Revenue
13.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction
13.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.8.5 Celgene Corp Recent Development
13.9 Cell Medica Ltd
13.9.1 Cell Medica Ltd Company Details
13.9.2 Cell Medica Ltd Business Overview and Its Total Revenue
13.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.9.5 Cell Medica Ltd Recent Development
13.10 Cellular Biomedicine Group Inc
13.10.1 Cellular Biomedicine Group Inc Company Details
13.10.2 Cellular Biomedicine Group Inc Business Overview and Its Total Revenue
13.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.10.5 Cellular Biomedicine Group Inc Recent Development
13.11 Celularity Inc
10.11.1 Celularity Inc Company Details
10.11.2 Celularity Inc Business Overview and Its Total Revenue
10.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.11.5 Celularity Inc Recent Development
13.12 Celyad SA
10.12.1 Celyad SA Company Details
10.12.2 Celyad SA Business Overview and Its Total Revenue
10.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction
10.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.12.5 Celyad SA Recent Development
13.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Company Details
10.13.2 Daiichi Sankyo Co Ltd Business Overview and Its Total Revenue
10.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.13.5 Daiichi Sankyo Co Ltd Recent Development
13.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Company Details
10.14.2 Fosun Pharmaceutical AG Business Overview and Its Total Revenue
10.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction
10.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.14.5 Fosun Pharmaceutical AG Recent Development
13.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Company Details
10.15.2 Gilead Sciences Inc Business Overview and Its Total Revenue
10.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.15.5 Gilead Sciences Inc Recent Development
13.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview and Its Total Revenue
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
13.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Company Details
10.17.2 Hangzhou Converd Co Ltd Business Overview and Its Total Revenue
10.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.17.5 Hangzhou Converd Co Ltd Recent Development
13.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
10.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview and Its Total Revenue
10.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
13.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Company Details
10.19.2 HRAIN Biotechnology Co Ltd Business Overview and Its Total Revenue
10.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.19.5 HRAIN Biotechnology Co Ltd Recent Development
13.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Company Details
10.20.2 Juno Therapeutics Inc Business Overview and Its Total Revenue
10.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.20.5 Juno Therapeutics Inc Recent Development
13.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Company Details
10.21.2 Kite Pharma Inc Business Overview and Its Total Revenue
10.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.21.5 Kite Pharma Inc Recent Development
13.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Company Details
10.22.2 Nanjing Legend Biotech Co Ltd Business Overview and Its Total Revenue
10.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.22.5 Nanjing Legend Biotech Co Ltd Recent Development
13.23 NantKwest Inc
10.23.1 NantKwest Inc Company Details
10.23.2 NantKwest Inc Business Overview and Its Total Revenue
10.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.23.5 NantKwest Inc Recent Development
13.24 Nkarta Inc
10.24.1 Nkarta Inc Company Details
10.24.2 Nkarta Inc Business Overview and Its Total Revenue
10.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.24.5 Nkarta Inc Recent Development
13.25 Novartis AG
10.25.1 Novartis AG Company Details
10.25.2 Novartis AG Business Overview and Its Total Revenue
10.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction
10.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.25.5 Novartis AG Recent Development
13.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Company Details
10.26.2 Ono Pharmaceutical Co Ltd Business Overview and Its Total Revenue
10.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.26.5 Ono Pharmaceutical Co Ltd Recent Development
13.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview and Its Total Revenue
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
13.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Company Details
10.28.2 Sorrento Therapeutics Inc Business Overview and Its Total Revenue
10.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.28.5 Sorrento Therapeutics Inc Recent Development
13.29 Takara Bio Inc
10.29.1 Takara Bio Inc Company Details
10.29.2 Takara Bio Inc Business Overview and Its Total Revenue
10.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.29.5 Takara Bio Inc Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Chimeric Antigen Receptor Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
Table 3. Ranking of Global Top Chimeric Antigen Receptor Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. COVID-19 Impact Global Market: (Four Chimeric Antigen Receptor Cell Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Chimeric Antigen Receptor Cell Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Chimeric Antigen Receptor Cell Therapy Players to Combat Covid-19 Impact
Table 12. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2015-2020)
Table 16. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Chimeric Antigen Receptor Cell Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Chimeric Antigen Receptor Cell Therapy Players
Table 23. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players (2015-2020)
Table 25. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2019)
Table 26. Global Chimeric Antigen Receptor Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
Table 29. Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Type (2015-2020)
Table 33. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Application (2015-2020)
Table 35. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 39. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 41. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 45. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 47. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 51. China Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 53. China Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 57. Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 59. Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 63. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 69. India Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 71. India Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 75. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 79. Amgen Inc Company Details
Table 80. Amgen Inc Business Overview
Table 81. Amgen Inc Product
Table 82. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 83. Amgen Inc Recent Development
Table 84. Autolus Therapeutics Plc Company Details
Table 85. Autolus Therapeutics Plc Business Overview
Table 86. Autolus Therapeutics Plc Product
Table 87. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 88. Autolus Therapeutics Plc Recent Development
Table 89. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
Table 90. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 91. Beijing Immunochina Medical Science & Technology Co Ltd Product
Table 92. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 93. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 94. Bellicum Pharmaceuticals Inc Company Details
Table 95. Bellicum Pharmaceuticals Inc Business Overview
Table 96. Bellicum Pharmaceuticals Inc Product
Table 97. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 98. Bellicum Pharmaceuticals Inc Recent Development
Table 99. Bristol-Myers Squibb Co Company Details
Table 100. Bristol-Myers Squibb Co Business Overview
Table 101. Bristol-Myers Squibb Co Product
Table 102. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Co Recent Development
Table 104. bluebird bio Inc Company Details
Table 105. bluebird bio Inc Business Overview
Table 106. bluebird bio Inc Product
Table 107. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 108. bluebird bio Inc Recent Development
Table 109. CARsgen Therapeutics Ltd Company Details
Table 110. CARsgen Therapeutics Ltd Business Overview
Table 111. CARsgen Therapeutics Ltd Product
Table 112. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 113. CARsgen Therapeutics Ltd Recent Development
Table 114. Celgene Corp Business Overview
Table 115. Celgene Corp Product
Table 116. Celgene Corp Company Details
Table 117. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 118. Celgene Corp Recent Development
Table 119. Cell Medica Ltd Company Details
Table 120. Cell Medica Ltd Business Overview
Table 121. Cell Medica Ltd Product
Table 122. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 123. Cell Medica Ltd Recent Development
Table 124. Cellular Biomedicine Group Inc Company Details
Table 125. Cellular Biomedicine Group Inc Business Overview
Table 126. Cellular Biomedicine Group Inc Product
Table 127. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 128. Cellular Biomedicine Group Inc Recent Development
Table 129. Celularity Inc Company Details
Table 130. Celularity Inc Business Overview
Table 131. Celularity Inc Product
Table 132. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 133. Celularity Inc Recent Development
Table 134. Celyad SA Company Details
Table 135. Celyad SA Business Overview
Table 136. Celyad SA Product
Table 137. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 138. Celyad SA Recent Development
Table 139. Daiichi Sankyo Co Ltd Company Details
Table 140. Daiichi Sankyo Co Ltd Business Overview
Table 141. Daiichi Sankyo Co Ltd Product
Table 142. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 143. Daiichi Sankyo Co Ltd Recent Development
Table 144. Fosun Pharmaceutical AG Company Details
Table 145. Fosun Pharmaceutical AG Business Overview
Table 146. Fosun Pharmaceutical AG Product
Table 147. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 148. Fosun Pharmaceutical AG Recent Development
Table 149. Gilead Sciences Inc Company Details
Table 150. Gilead Sciences Inc Business Overview
Table 151. Gilead Sciences Inc Product
Table 152. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 153. Gilead Sciences Inc Recent Development
Table 154. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
Table 155. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 156. Guangzhou Anjie Biomedical Technology Co Ltd Product
Table 157. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 158. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 159. Hangzhou Converd Co Ltd Company Details
Table 160. Hangzhou Converd Co Ltd Business Overview
Table 161. Hangzhou Converd Co Ltd Product
Table 162. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 163. Hangzhou Converd Co Ltd Recent Development
Table 164. Hebei Senlang Biotechnology Inc Ltd Company Details
Table 165. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 166. Hebei Senlang Biotechnology Inc Ltd Product
Table 167. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 168. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 169. HRAIN Biotechnology Co Ltd Company Details
Table 170. HRAIN Biotechnology Co Ltd Business Overview
Table 171. HRAIN Biotechnology Co Ltd Product
Table 172. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 173. HRAIN Biotechnology Co Ltd Recent Development
Table 174. Juno Therapeutics Inc Company Details
Table 175. Juno Therapeutics Inc Business Overview
Table 176. Juno Therapeutics Inc Product
Table 177. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 178. Juno Therapeutics Inc Recent Development
Table 179. Kite Pharma Inc Company Details
Table 180. Kite Pharma Inc Business Overview
Table 181. Kite Pharma Inc Product
Table 182. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 183. Kite Pharma Inc Recent Development
Table 184. Nanjing Legend Biotech Co Ltd Company Details
Table 185. Nanjing Legend Biotech Co Ltd Business Overview
Table 186. Nanjing Legend Biotech Co Ltd Product
Table 187. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 188. Nanjing Legend Biotech Co Ltd Recent Development
Table 189. NantKwest Inc Company Details
Table 190. NantKwest Inc Business Overview
Table 191. NantKwest Inc Product
Table 192. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 193. NantKwest Inc Recent Development
Table 194. Nkarta Inc Company Details
Table 195. Nkarta Inc Business Overview
Table 196. Nkarta Inc Product
Table 197. Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 198. Nkarta Inc Recent Development
Table 199. Novartis AG Company Details
Table 200. Novartis AG Business Overview
Table 201. Novartis AG Product
Table 202. Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 203. Novartis AG Recent Development
Table 204. Ono Pharmaceutical Co Ltd Company Details
Table 205. Ono Pharmaceutical Co Ltd Business Overview
Table 206. Ono Pharmaceutical Co Ltd Product
Table 207. Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 208. Ono Pharmaceutical Co Ltd Recent Development
Table 209. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
Table 210. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 211. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Product
Table 212. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 213. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
Table 214. Sorrento Therapeutics Inc Company Details
Table 215. Sorrento Therapeutics Inc Business Overview
Table 216. Sorrento Therapeutics Inc Product
Table 217. Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 218. Sorrento Therapeutics Inc Recent Development
Table 219. Takara Bio Inc Company Details
Table 220. Takara Bio Inc Business Overview
Table 221. Takara Bio Inc Product
Table 222. Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 223. Takara Bio Inc Recent Development
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
Table 1. Chimeric Antigen Receptor Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
Table 3. Ranking of Global Top Chimeric Antigen Receptor Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. COVID-19 Impact Global Market: (Four Chimeric Antigen Receptor Cell Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Chimeric Antigen Receptor Cell Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Chimeric Antigen Receptor Cell Therapy Players to Combat Covid-19 Impact
Table 12. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2015-2020)
Table 16. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Chimeric Antigen Receptor Cell Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Chimeric Antigen Receptor Cell Therapy Players
Table 23. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players (2015-2020)
Table 25. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2019)
Table 26. Global Chimeric Antigen Receptor Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
Table 29. Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Type (2015-2020)
Table 33. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Application (2015-2020)
Table 35. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 39. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 41. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 45. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 47. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 51. China Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 53. China Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 57. Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 59. Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 63. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 69. India Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 71. India Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 75. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 79. Amgen Inc Company Details
Table 80. Amgen Inc Business Overview
Table 81. Amgen Inc Product
Table 82. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 83. Amgen Inc Recent Development
Table 84. Autolus Therapeutics Plc Company Details
Table 85. Autolus Therapeutics Plc Business Overview
Table 86. Autolus Therapeutics Plc Product
Table 87. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 88. Autolus Therapeutics Plc Recent Development
Table 89. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
Table 90. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 91. Beijing Immunochina Medical Science & Technology Co Ltd Product
Table 92. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 93. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 94. Bellicum Pharmaceuticals Inc Company Details
Table 95. Bellicum Pharmaceuticals Inc Business Overview
Table 96. Bellicum Pharmaceuticals Inc Product
Table 97. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 98. Bellicum Pharmaceuticals Inc Recent Development
Table 99. Bristol-Myers Squibb Co Company Details
Table 100. Bristol-Myers Squibb Co Business Overview
Table 101. Bristol-Myers Squibb Co Product
Table 102. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Co Recent Development
Table 104. bluebird bio Inc Company Details
Table 105. bluebird bio Inc Business Overview
Table 106. bluebird bio Inc Product
Table 107. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 108. bluebird bio Inc Recent Development
Table 109. CARsgen Therapeutics Ltd Company Details
Table 110. CARsgen Therapeutics Ltd Business Overview
Table 111. CARsgen Therapeutics Ltd Product
Table 112. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 113. CARsgen Therapeutics Ltd Recent Development
Table 114. Celgene Corp Business Overview
Table 115. Celgene Corp Product
Table 116. Celgene Corp Company Details
Table 117. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 118. Celgene Corp Recent Development
Table 119. Cell Medica Ltd Company Details
Table 120. Cell Medica Ltd Business Overview
Table 121. Cell Medica Ltd Product
Table 122. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 123. Cell Medica Ltd Recent Development
Table 124. Cellular Biomedicine Group Inc Company Details
Table 125. Cellular Biomedicine Group Inc Business Overview
Table 126. Cellular Biomedicine Group Inc Product
Table 127. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 128. Cellular Biomedicine Group Inc Recent Development
Table 129. Celularity Inc Company Details
Table 130. Celularity Inc Business Overview
Table 131. Celularity Inc Product
Table 132. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 133. Celularity Inc Recent Development
Table 134. Celyad SA Company Details
Table 135. Celyad SA Business Overview
Table 136. Celyad SA Product
Table 137. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 138. Celyad SA Recent Development
Table 139. Daiichi Sankyo Co Ltd Company Details
Table 140. Daiichi Sankyo Co Ltd Business Overview
Table 141. Daiichi Sankyo Co Ltd Product
Table 142. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 143. Daiichi Sankyo Co Ltd Recent Development
Table 144. Fosun Pharmaceutical AG Company Details
Table 145. Fosun Pharmaceutical AG Business Overview
Table 146. Fosun Pharmaceutical AG Product
Table 147. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 148. Fosun Pharmaceutical AG Recent Development
Table 149. Gilead Sciences Inc Company Details
Table 150. Gilead Sciences Inc Business Overview
Table 151. Gilead Sciences Inc Product
Table 152. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 153. Gilead Sciences Inc Recent Development
Table 154. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
Table 155. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 156. Guangzhou Anjie Biomedical Technology Co Ltd Product
Table 157. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 158. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 159. Hangzhou Converd Co Ltd Company Details
Table 160. Hangzhou Converd Co Ltd Business Overview
Table 161. Hangzhou Converd Co Ltd Product
Table 162. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 163. Hangzhou Converd Co Ltd Recent Development
Table 164. Hebei Senlang Biotechnology Inc Ltd Company Details
Table 165. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 166. Hebei Senlang Biotechnology Inc Ltd Product
Table 167. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 168. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 169. HRAIN Biotechnology Co Ltd Company Details
Table 170. HRAIN Biotechnology Co Ltd Business Overview
Table 171. HRAIN Biotechnology Co Ltd Product
Table 172. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 173. HRAIN Biotechnology Co Ltd Recent Development
Table 174. Juno Therapeutics Inc Company Details
Table 175. Juno Therapeutics Inc Business Overview
Table 176. Juno Therapeutics Inc Product
Table 177. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 178. Juno Therapeutics Inc Recent Development
Table 179. Kite Pharma Inc Company Details
Table 180. Kite Pharma Inc Business Overview
Table 181. Kite Pharma Inc Product
Table 182. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 183. Kite Pharma Inc Recent Development
Table 184. Nanjing Legend Biotech Co Ltd Company Details
Table 185. Nanjing Legend Biotech Co Ltd Business Overview
Table 186. Nanjing Legend Biotech Co Ltd Product
Table 187. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 188. Nanjing Legend Biotech Co Ltd Recent Development
Table 189. NantKwest Inc Company Details
Table 190. NantKwest Inc Business Overview
Table 191. NantKwest Inc Product
Table 192. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 193. NantKwest Inc Recent Development
Table 194. Nkarta Inc Company Details
Table 195. Nkarta Inc Business Overview
Table 196. Nkarta Inc Product
Table 197. Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 198. Nkarta Inc Recent Development
Table 199. Novartis AG Company Details
Table 200. Novartis AG Business Overview
Table 201. Novartis AG Product
Table 202. Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 203. Novartis AG Recent Development
Table 204. Ono Pharmaceutical Co Ltd Company Details
Table 205. Ono Pharmaceutical Co Ltd Business Overview
Table 206. Ono Pharmaceutical Co Ltd Product
Table 207. Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 208. Ono Pharmaceutical Co Ltd Recent Development
Table 209. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
Table 210. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 211. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Product
Table 212. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 213. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
Table 214. Sorrento Therapeutics Inc Company Details
Table 215. Sorrento Therapeutics Inc Business Overview
Table 216. Sorrento Therapeutics Inc Product
Table 217. Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 218. Sorrento Therapeutics Inc Recent Development
Table 219. Takara Bio Inc Company Details
Table 220. Takara Bio Inc Business Overview
Table 221. Takara Bio Inc Product
Table 222. Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 223. Takara Bio Inc Recent Development
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Acute Leukemia Case Studies
Figure 6. Non-hodgkin's Lymphoma Case Studies
Figure 7. Multiple Myeloma Case Studies
Figure 8. Transplant Rejection Case Studies
Figure 9. Other Case Studies
Figure 10. Chimeric Antigen Receptor Cell Therapy Report Years Considered
Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players in 2019
Figure 16. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2019
Figure 18. North America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Amgen Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 27. Autolus Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Autolus Therapeutics Plc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 29. Beijing Immunochina Medical Science & Technology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 31. Bellicum Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 33. Bristol-Myers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Co Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 35. bluebird bio Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. bluebird bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 37. CARsgen Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. CARsgen Therapeutics Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 39. Celgene Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Celgene Corp Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 41. Cell Medica Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Cell Medica Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 43. Cellular Biomedicine Group Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cellular Biomedicine Group Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 45. Celularity Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Celularity Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 47. Celyad SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Celyad SA Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 49. Daiichi Sankyo Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Daiichi Sankyo Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 51. Fosun Pharmaceutical AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Fosun Pharmaceutical AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 53. Gilead Sciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Gilead Sciences Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 55. Guangzhou Anjie Biomedical Technology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 57. Hangzhou Converd Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Hangzhou Converd Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 59. Hebei Senlang Biotechnology Inc Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 61. HRAIN Biotechnology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 63. Juno Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Juno Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Acute Leukemia Case Studies
Figure 6. Non-hodgkin's Lymphoma Case Studies
Figure 7. Multiple Myeloma Case Studies
Figure 8. Transplant Rejection Case Studies
Figure 9. Other Case Studies
Figure 10. Chimeric Antigen Receptor Cell Therapy Report Years Considered
Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players in 2019
Figure 16. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2019
Figure 18. North America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Amgen Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 27. Autolus Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Autolus Therapeutics Plc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 29. Beijing Immunochina Medical Science & Technology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 31. Bellicum Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 33. Bristol-Myers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Co Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 35. bluebird bio Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. bluebird bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 37. CARsgen Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. CARsgen Therapeutics Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 39. Celgene Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Celgene Corp Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 41. Cell Medica Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Cell Medica Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 43. Cellular Biomedicine Group Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cellular Biomedicine Group Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 45. Celularity Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Celularity Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 47. Celyad SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Celyad SA Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 49. Daiichi Sankyo Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Daiichi Sankyo Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 51. Fosun Pharmaceutical AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Fosun Pharmaceutical AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 53. Gilead Sciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Gilead Sciences Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 55. Guangzhou Anjie Biomedical Technology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 57. Hangzhou Converd Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Hangzhou Converd Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 59. Hebei Senlang Biotechnology Inc Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 61. HRAIN Biotechnology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 63. Juno Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Juno Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed